- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03033953
Effects of Native Whey or Milk Supplementation on Adaptations to 12 Weeks of Strength Training in Young and Elderly
Effects of Native Whey and Milk Supplementation on Changes in Muscle Mass and Strength After 12 Weeks of Strength Training in Young and Elderly
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than milk. Of special interest is the higher amounts of the highly anabolic amino acid leucine in native whey.
The higher levels of leucine can be of great interest for elderly individuals as some studies in elderly has shown an anabolic resistance to the effects of protein feeding and strength training. By increasing levels of leucine one might overcome this anabolic resistance in the elderly.
The aim of this double-blinded, randomized, partial cross-over study is to compare the changes in muscle hypertrophy and strength after a 11 (elderly) or 12 (young) week training intervention with daily supplementation of either 2x20g of native whey or milk proteins in young and elderly individuals. In order to explain potential differences between supplements an acute study investigating acute responses in blood amino acid concentrations and intracellular signalling is planned, in a subgroup of participants, before and after the training intervention.
The investigators hypothesize that native whey will induce greater muscle hypertrophy and strength gains than milk.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Oslo, Norge, 0863
- Norwegian School of Sport Sciences
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Healthy in the sense that they can conduct training and testing
- Able to understand Norwegian language written and oral
- Between 20 and 45, or above 70 years of age
Exclusion Criteria:
- Diseases or injuries contraindicating participation
- Use of dietary supplements (e.g. proteins, vitamins and creatine)
- Lactose intolerance
- Allergy to milk
- Allergy towards local anesthetics (xylocain)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Placebo-jämförare: Milk supplementation
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g milk protein.
|
|
Experimentell: Native whey
11 (elderly) or 12 (young) weeks of strength training and daily supplementation of 2x20g native whey protein.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Lean mass
Tidsram: Before the training intervention
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
Before the training intervention
|
Lean mass
Tidsram: After 11-12 weeks of strength training
|
Measured by whole body dual x-ray absorptiometry (DXA)
|
After 11-12 weeks of strength training
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Thigh muscle cross sectional area
Tidsram: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
Thigh muscle cross sectional area
Tidsram: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
Pectoralis muscle cross sectional area
Tidsram: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
Pectoralis muscle cross sectional area
Tidsram: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
Arm cross sectional area
Tidsram: Before the training intervention
|
Measured by magnetic resonance imaging (MRI)
|
Before the training intervention
|
Arm cross sectional area
Tidsram: After 11-12 weeks of strength training
|
Measured by magnetic resonance imaging (MRI)
|
After 11-12 weeks of strength training
|
Thickness of the lateral vasti
Tidsram: Before the training intervention
|
Measured by ultrasound
|
Before the training intervention
|
Thickness of the lateral vasti
Tidsram: After 11-12 weeks of strength training
|
Measured by ultrasound
|
After 11-12 weeks of strength training
|
1 repetition maximum in leg press
Tidsram: Before the training intervention
|
Before the training intervention
|
|
1 repetition maximum in leg press
Tidsram: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
1 repetition maximum in bench press
Tidsram: Before the training intervention
|
Before the training intervention
|
|
1 repetition maximum in bench press
Tidsram: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Tidsram: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Ratio of phosphorylated to total ribosomal protein S6 kinase beta-1(P70S6K) change from baseline
Tidsram: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Tidsram: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Phosphorylation of phosphorylated to total eukaryotic elongation factor 2 (eEF-2) change from baseline
Tidsram: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Tidsram: 30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, before the training intervention
|
Phosphorylation of phosphorylated to total eukaryotic translation initiation factor 4E-binding protein 1 (4EBP-1) change from baseline
Tidsram: 30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Biopsies from m. Vastus Lateralis was analyzed by western blot
|
30 min before and 2 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Plasma amino acid concentration
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Plasma amino acid concentration
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Muscle force generating capacity change from baseline
Tidsram: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, before the training intervention
|
Muscle force generating capacity change from baseline
Tidsram: 15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Measured as unilateral isometric knee extension force (Nm) with 90° in the hip and knee joints.
|
15 min before, 10 min, 2.5 hours and 24 hours after exercise and protein supplement intake, after 11-12 weeks of strength training
|
Serum glucose
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum glucose
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum insulin
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum insulin
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum urea
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum urea
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Serum creatine kinase
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, before the training intervention
|
|
Serum creatine kinase
Tidsram: 60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
60 min before and 45, 60, 75 and 120 min after exercise and protein supplement intake, after 11-12 weeks of strength training
|
|
Tumor necrosis factor alfa messenger ribonucleic acid (mRNA)
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Tumor necrosis factor alfa mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Tumor necrosis factor alfa mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Tumor necrosis factor alfa mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 6 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 6 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 6 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 6 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 8 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 8 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 8 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 8 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 2 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1b mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 1b mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 1b mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1b mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1 Receptor Antagonist mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 1 Receptor Antagonist mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 1 Receptor Antagonist mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 1 Receptor Antagonist mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 2 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 2 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 2 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 2 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 4 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 4 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 4 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 4 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 10 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 10 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 10 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 10 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Cholesterol 25-Hydroxylase mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Cholesterol 25-Hydroxylase mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Cholesterol 25-Hydroxylase mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Cholesterol 25-Hydroxylase mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 8 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 8 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 8 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 8 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 17D mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Interleukin 17D mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Interleukin 17D mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Interleukin 17D mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 3 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 3 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 3 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 3 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-X-C Motif Chemokine Ligand 16 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 5 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 5 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
C-C Motif Chemokine Ligand 5 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
C-C Motif Chemokine Ligand 5 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 4 Group A Member 3 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Uncoupling Protein 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Uncoupling Protein 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Uncoupling Protein 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Uncoupling Protein 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Matrix Metallopeptidase 9 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Matrix Metallopeptidase 9 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Matrix Metallopeptidase 9 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Matrix Metallopeptidase 9 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
ATP Binding Cassette Subfamily A Member 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Leukocyte Differentiation Antigen CD36 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Toll Like Receptor 2 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Toll Like Receptor 2 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Toll Like Receptor 2 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Toll Like Receptor 2 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Nuclear Receptor Subfamily 1 Group H Member 3 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 3 Member 2 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 3 Member 2 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 3 Member 2 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 3 Member 2 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 7 Member 5 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 7 Member 5 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 7 Member 5 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 7 Member 5 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 36 Member 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 36 Member 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 36 Member 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 36 Member 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 38 Member 2 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Solute Carrier Family 38 Member 2 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Solute Carrier Family 38 Member 2 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Solute Carrier Family 38 Member 2 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Muscle-Specific RING Finger Protein 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Atrogin-1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Atrogin-1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Atrogin-1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Atrogin-1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box Protein O1A mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Forkhead Box Protein O1A mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Forkhead Box Protein O1A mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box Protein O1A mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box O3 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Forkhead Box O3 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Forkhead Box O3 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Forkhead Box O3 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 7 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 7 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 7 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 7 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 2 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 2 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 2 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 2 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myosin Heavy Chain 1mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myosin Heavy Chain 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Insulin Like Growth Factor 1 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Mast Cell Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Hepatocyte Growth Factor mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Myostatin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Striated Muscle Activator Of Rho-Dependent Signaling mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
JunB Proto-Oncogene, AP-1 Transcription Factor Subunit mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Actin, Alpha 1, Skeletal Muscle mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Colony Stimulating Factor 3 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Prostaglandin-Endoperoxide Synthase 2 mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
TATA-Box Binding Protein mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Filamin B mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
2 hours after exercise and protein intake, after 11-12 weeks of strength training
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, before training intervention
|
30 min before exercise and protein intake, before training intervention
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 2 hours after exercise and protein intake, before training intervention
|
2 hours after exercise and protein intake, before training intervention
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min before exercise and protein intake, after 11-12 weeks of strength training
|
30 min before exercise and protein intake, after 11-12 weeks of strength training
|
|
Beta-2-Microglobulin mRNA Myosin Heavy Chain 1 mRNA
Tidsram: 30 min after exercise and protein intake, after 11-12 weeks of strength training
|
30 min after exercise and protein intake, after 11-12 weeks of strength training
|
|
Fasting cholesterol (only in elderly)
Tidsram: Before training intervention
|
Before training intervention
|
|
Fasting cholesterol (only in elderly)
Tidsram: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Fasting triglycerides (only in elderly)
Tidsram: Before training intervention
|
Before training intervention
|
|
Fasting triglycerides (only in elderly)
Tidsram: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Fasting LDL (only in elderly)
Tidsram: Before training intervention
|
Before training intervention
|
|
Fasting LDL (only in elderly)
Tidsram: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
|
Fasting HDL (only in elderly)
Tidsram: Before training intervention
|
Before training intervention
|
|
Fasting HDL (only in elderly)
Tidsram: After 11-12 weeks of strength training
|
After 11-12 weeks of strength training
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- Tine 12wk
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Friska
-
University of MiamiJames and Esther King Biomedical Research ProgramAvslutadHealthy Lifetime Icke-rökareFörenta staterna
-
University of LeicesterNational Institute for Health Research, United KingdomAvslutadPatienter med hjärtsvikt och konserverad ejektionsfraktion - HFpEF | Patienter med hjärtsvikt med reducerad ejektionsfraktion - HFrEF | Healthy Controls Group - ålders- och könsmatchad
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesAvslutadParkinsons sjukdom | Healthy Controls Group - ålders- och könsmatchadFrankrike
Kliniska prövningar på Styrketräning
-
Shin Kong Wu Ho-Su Memorial HospitalAvslutad
-
VA Office of Research and DevelopmentUniversity of Colorado, DenverAvslutadArtros | Total höftprotesplastikFörenta staterna
-
Ablon Skin Institute Research CenterIrish Response t/a Lifes2goodAvslutad
-
University of California, San FranciscoAvslutad
-
Madonna Rehabilitation HospitalAktiv, inte rekryterandeNeurologisk skada | Neurologiska sjukdomar eller tillståndFörenta staterna
-
Yale UniversityAvslutadPsykisk hälsoproblem (t.ex. depression, psykos, personlighetsstörning, missbruk) | Psykisk hälsa 1 | Krigsrelaterat traumaJordanien
-
Kessler FoundationHar inte rekryterat ännu
-
University of HawaiiNational Institute on Drug Abuse (NIDA); University of Maryland, BaltimoreOkänd
-
Florida State UniversityRekrytering
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health...Avslutad